CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 4,501 | +0.6% | 0.00% | – |
| Q2 2021 | $19,000 | -9.5% | 4,472 | +8.5% | 0.00% | – |
| Q1 2021 | $21,000 | +23.5% | 4,123 | +191.4% | 0.00% | – |
| Q1 2019 | $17,000 | -43.3% | 1,415 | -41.5% | 0.00% | – |
| Q4 2018 | $30,000 | -16.7% | 2,419 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,419 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -25.5% | 2,419 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -62.6% | 2,419 | -57.3% | 0.00% | -100.0% |
| Q4 2017 | $147,000 | +110.0% | 5,668 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +6.1% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -18.5% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +65.3% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | – | 4,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |